VL

Venkata Lavanya Guda

Director Director DIN 05222588
DIN 05222588 First appointment Mar 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2012
Shareholding value •••• Premium profile

About Venkata Lavanya Guda

Data last updated:

Venkata Lavanya Guda was a Director at Kosher Pharmaceutical Private Limited (2012–2015) and Director at Elite Pharmaceutical Private Limited (2012–2015). The companies operate in Pharma.

DIN 05222588
Primary Designation Director
Industry Pharma
First Appointment 29 Mar 2012

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Mar 20122012₹33.59 Cr (FY 2020)Active
Elite Pharmaceutical Private Limited U24232TG2012PTC080006
Director29 Mar 20122012Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kosher Pharmaceutical Private Limited
Elite Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Venkata Lavanya Guda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Lavanya Guda

Venkata Lavanya Guda was first appointed on 29 Mar 2012 as Director at Kosher Pharmaceutical Private Limited.

Venkata Lavanya Guda held 2 earlier board appointments: Kosher Pharmaceutical Private Limited (Director, 29 Mar 2012 to 09 Nov 2015); Elite Pharmaceutical Private Limited (Director, 29 Mar 2012 to 09 Nov 2015).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available